Piera Capranzano

Showing 1-20 of 20 articles

Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries

Caixeta A, Campos C, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, Costa Jr J, Onuma Y, van Geuns R, Bartorelli A, Colombo A, Tamburino C, Serruys P, Abizaid A

September 20, 2019 | 10.4244/EIJ-D-16-00796

De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

Capranzano P, Angiolillo D

August 9, 2019 | 10.4244/EIJV15I6A89

Other

Radiation protection measures and sex distribution in European interventional catheterization laboratories: Results from the EAPCI Women's survey

Manzo-Silberman S, Piccaluga E, Radu M, James S, Schüpke S, Vaquerizo B, Kunadian V, Capranzano P, Mehilli J, Buchanan G, Chieffo A, Mauri J

March 19, 2019 | 10.4244/EIJ-D-18-01044

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee

Chieffo A, Buchanan G, Mehilli J, Capodanno D, Kunadian V, Petronio A, Mikhail G, Capranzano P, Gonzalo N, Karam N, Manzo-Silberman S, Schüpke S, Byrne R, Capretti G, Appelman Y, Morice M, Presbitero P, Radu M, Mauri J

December 7, 2018 | 10.4244/EIJ-D-18-00225

Appraisal of key trials in aortic and mitral fields

Capranzano P, Van Mieghem N, Tamburino C

September 7, 2018 | 10.4244/EIJ-D-18-00544

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabaté M, Tamburino C, Nef H, Gori T

October 11, 2017 | 10.4244/EIJ-D-16-00568

Coronary interventions

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

Interventions for valvular disease

Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II)

Petronio A, Capranzano P, Barbato E, Piazza N, Baumbach A, Haude M, Windecker S

March 20, 2017 | 10.4244/EIJ-D-16-00678

Coronary interventions

Current status of transcatheter valve therapy in Europe: results from an EAPCI survey

Petronio A, Capranzano P, Barbato E, Piazza N, Baumbach A, Haude M, Windecker S

September 18, 2016 | 10.4244/EIJY16M06_01

Coronary interventions

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabaté M, Mattesini A, Geraci S, Naber C, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T

August 5, 2016 | 10.4244/EIJY15M09_10

Coronary interventions

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S-J, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber C

August 5, 2016 | 10.4244/EIJV12I5A102

Coronary interventions

One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice

Capranzano P, Longo G, Tamburino Cl, Gargiulo G, Ohno Y, Francaviglia B, La Manna A, Di Salvo M-E, Grasso C, Sgroi C, Capodanno D, Tamburino C

June 10, 2016 | 10.4244/EIJV12I2A28

Coronary interventions

Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey

Capranzano P, Kunadian V, Mauri J, Petronio A, Salvatella N, Appelman Y, Gilard M, Mikhail G, Schüpke S, Radu M, Vaquerizo B, Presbitero P, Morice M, Mehilli J

May 16, 2016 | 10.4244/EIJY15M07_03

Interventions for valvular disease

Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry

Ohno Y, Attizzani G, Capodanno D, Barbanti M, Cannata S, Dipasqua F, Imme S, Ministeri M, Caggegi A, Pistritto A, Chiaranda M, Ronsivalle G, Giaquinta S, Mangiafico S, Scandura S, Capranzano P, Tamburino C, Grasso C

April 8, 2016 | 10.4244/EIJV11I14A316

Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation

Barbanti M, Capranzano P, Ohno Y, Gulino S, Sgroi C, Imme S, Tamburino Cl, Cannata S, Patane M, Di Stefano D, Todaro D, Di Simone E, Deste W, Gargiulo G, Capodanno D, Grasso C, Tamburino C

October 20, 2015 | 10.4244/EIJV11I6A137

Coronary interventions

Bioresorbable vascular scaffolds in left main coronary artery disease

Everaert B, Capranzano P, Tamburino C, Seth A, van Geuns R

May 19, 2015 | 10.4244/EIJV11SVA30

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective

Tamburino C, Latib A, van Geuns R, Sabaté M, Mehilli J, Gori T, Achenbach S, Alvarez M, Nef H, Lesiak M, Di Mario C, Colombo A, Naber C, Caramanno G, Capranzano P, Brugaletta S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras S, Rzeszutko L, Depukat R, Diletti R, Boone E, Capodanno D, Dudek D

May 19, 2015 | 10.4244/EIJY15M01_05

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C

February 20, 2015 | 10.4244/EIJY14M07_11

Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry

Meliga E, De Benedictis M, Chieffo A, Latib A, Park S-J, Kim Y, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Bande M, Chakravarty T, Mehran R, Naber C, Scrocca I, Margey R, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Conte M, Serruys P, Colombo A

November 29, 2013 | 10.4244/EIJV9I7A133

Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry

Tamburino C, Capodanno D, Di Salvo M-E, Sanfilippo A, Cascone I, Incardona V, Longo G, Giacoppo D, Capranzano P, Sgroi C, Ussia G, Monaco A, La Manna A

January 20, 2012 | 10.4244/EIJV7I9A169

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Piera Capranzano

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke